Ketonal Intensive

Ketoprofen Lysine, the active ingredient in Ketonal Intensive, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It is employed to relieve mild to moderate pain and to reduce inflammation in conditions such as musculoskeletal disorders, rheumatoid arthritis, osteoarthritis, and dental pain.

GNH USA supplies Ketonal Intensive as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution across multiple regulatory jurisdictions.

Ketoprofen Lysine is indicated for several painful and inflammatory conditions affecting the musculoskeletal and dental systems.

Mild to moderate pain: provides analgesic relief for temporary discomfort such as headaches or minor injuries. Musculoskeletal pain: reduces inflammation and pain associated with strains, sprains, and backache. Rheumatoid arthritis: helps control joint inflammation and stiffness in chronic autoimmune disease. Osteoarthritis: alleviates pain and improves joint function in degenerative joint disease. Dental pain: diminishes postoperative or inflammatory pain following dental procedures.

Ketoprofen Lysine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient vertigo or light‑headedness.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding: potentially life‑threatening hemorrhage. - Hepatic injury: elevated liver enzymes or hepatitis. - Severe skin reactions: Stevens‑Johnson syndrome, toxic epidermal necrolysis, or anaphylaxis.

When prescribing Ketoprofen Lysine, clinicians should consider several safety precautions to minimise risk.

- Assess renal function: evaluate kidney health before initiating therapy, especially in elderly patients. - Monitor hepatic status: check liver enzymes periodically in patients with pre‑existing liver disease. - Evaluate cardiovascular risk: use cautiously in individuals with history of heart disease or hypertension. - Review gastrointestinal history: avoid in patients with active ulcers or prior gastrointestinal bleeding. - Avoid concurrent NSAIDs: do not combine with other non‑steroidal anti‑inflammatory drugs to reduce additive toxicity. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Ketoprofen Lysine can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective COX‑2 inhibitors: additive gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function when combined. - Diuretics: heightened risk of renal impairment and electrolyte imbalance. - Lithium: NSAIDs can raise lithium serum levels, risking toxicity.